Rimonabant inhibits human colon cancer c
β
Antonietta Santoro; Simona Pisanti; Claudia Grimaldi; Angelo A. Izzo; Francesca
π
Article
π
2009
π
John Wiley and Sons
π
French
β 301 KB
π 1 views
## Abstract The selective CB1 receptor antagonist rimonabant (SR141716) was shown to perform a number of biological effects in several pathological conditions. Emerging findings demonstrate that rimonabant exerts antitumor action in thyroid tumors and breast cancer cells. In our study, human colore